Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Microport EP and Stereotaxis Form Robotic Ablation Device Collaboration

publication date: Aug 30, 2021

Shanghai Microport EP Medtech and Stereotaxis of St. Louis will collaborate to develop advanced robotic electophysiology devices. The companies will combine MicroPort EP’s electrophysiology products with Stereotaxis’ advanced Robotic Magnetic Navigation technology. MicroPort EP will become the exclusive distributor of Stereotaxis’ electrophysiology technology in China. The companies will integrate MicroPort EP’s Columbus® mapping system with Stereotaxis’ robotic systems, and they will work together to develop a family of cardiac ablation and diagnostic catheters. More details....

Stock Symbol: (NYSE: STXS)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China